0001437749-21-009955.txt : 20210428 0001437749-21-009955.hdr.sgml : 20210428 20210428083227 ACCESSION NUMBER: 0001437749-21-009955 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191231 FILED AS OF DATE: 20210428 DATE AS OF CHANGE: 20210428 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tarrabain Alex CENTRAL INDEX KEY: 0001736937 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55557 FILM NUMBER: 21861511 MAIL ADDRESS: STREET 1: 18908 89 AVENUE CITY: EDMONTON STATE: A0 ZIP: T5T 6B7 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEN BIOTECH INC CENTRAL INDEX KEY: 0001653821 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300-3295 QUALITY WAY CITY: WINDSOR STATE: A6 ZIP: N8T 3R9 BUSINESS PHONE: 226-344-0660 MAIL ADDRESS: STREET 1: 300-3295 QUALITY WAY CITY: WINDSOR STATE: A6 ZIP: N8T 3R9 5 1 rdgdoc.xml FORM 5 X0306 5 2019-12-31 0 1 0001653821 CEN BIOTECH INC CENBF 0001736937 Tarrabain Alex 300-3295 QUALITY WAY WINDSOR, ONTARIO, CANADA A6 N8T 3R9 ONTARIO, CANADA 1 1 Chief Financial Officer Common Stock 2019-01-16 4 J 0 L 3000 0 A 1421942 D Common Stock 2019-02-16 4 J 0 L 3000 0 A 1421942 D Common Stock 2019-03-16 4 J 0 L 3000 0 A 1421942 D Common Stock 2019-04-16 4 J 0 L 3000 0 A 1421942 D Common Stock 2019-05-16 4 J 0 L 3000 0 A 1421942 D Common Stock 2019-05-16 4 A 0 L 1250000 0 A 1421942 D Common Stock 2019-06-16 4 J 0 L 3000 0 A 1421942 D Common Stock 2019-07-16 4 J 0 L 3000 0 A 1421942 D Common Stock 2019-08-16 4 J 0 L 3000 0 A 1421942 D Common Stock 2019-09-16 4 J 0 L 3000 0 A 1421942 D Common Stock 2019-10-16 4 J 0 L 3000 0 A 1421942 D Common Stock 2019-11-16 4 J 0 L 3000 0 A 1421942 D Common Stock 2019-12-16 4 J 0 L 3000 0 A 1421942 D 36,000 shares of common stock of the issuer were issued as consideration for extending the maturity date of a promissory note dated January 14, 2018 and were acquired in increments of 3,000 shares on the following dates: 01/16/2019; 02/16/2019; 03/16/2019; 04/16/2019; 05/16/2019; 06/16/2019; 07/16/2019; 08/16/2019; 09/16/2019; 10/16/2019; 11/16/2019 and 12/16/2019. Includes 30,000 shares issuable upon conversion of a convertible promissory note held by the reporting person which was issued on October 26, 2016 in the amount of $48,000. 1,250,000 shares of common stock of the issuer were granted by the issuer on May 16, 2019, pursuant to a restricted stock agreement pursuant to the issuer's equity compensation plan and the issuance was approved by the issuer's full board of directors. /s/ Alex Tarrabain 2021-04-28